ARTICLE
Received 3 Oct 2014 | Accepted 26 Aug 2015 | Published 7 Oct 2015
Donald G. Phinney1,*, Michelangelo Di Giuseppe2,*, Joel Njah2, Ernest Sala3, Sruti Shiva4,Claudette M. St Croix2,4,5, Donna B. Stolz5, Simon C. Watkins5, Y. Peter Di2, George D. Leikauf2, Jay Kolls6,
David W.H. Riches7, Giuseppe Deiuliis8, Naftali Kaminski8, Siddaraju V. Boregowda1, David H. McKenna9 & Luis A. Ortiz2
Mesenchymal stem cells (MSCs) and macrophages are fundamental components of the stem cell niche and function coordinately to regulate haematopoietic stem cell self-renewal and mobilization. Recent studies indicate that mitophagy and healthy mitochondrial function are critical to the survival of stem cells, but how these processes are regulated in MSCs is unknown. Here we show that MSCs manage intracellular oxidative stress by targeting depolarized mitochondria to the plasma membrane via arrestin domain-containing protein 1-mediated microvesicles. The vesicles are then engulfed and re-utilized via a process involving fusion by macrophages, resulting in enhanced bioenergetics. Furthermore, we show that MSCs simultaneously shed micro RNA-containing exosomes that inhibit macrophage activation by suppressing Toll-like receptor signalling, thereby de-sensitizing macrophages to the ingested mitochondria. Collectively, these studies mechanistically link mitophagy and MSC survival with macrophage function, thereby providing a physiologically relevant context for the innate immunomodulatory activity of MSCs.
1 Department of Molecular Therapeutics, The Scripps Research Institute, Jupiter, Florida 33458, USA. 2 Department of Environmental and Occupational Health, University of Pittsburgh, Pittsburgh, Pennsylvania 15219, USA. 3 Hospital Son Espases, Palma Mallorca 07010, Spain. 4 Department of Pharmacology, University of Pittsburgh, Pittsburgh, Pennsylvania 15219, USA. 5 Department of Cell Biology, University of Pittsburgh, Pittsburgh, Pennsylvania 15219, USA.
6 Mellon Foundation Institute for Pediatric Research, University of Pittsburgh, Pittsburgh, Pennsylvania 15219, USA. 7 Department of Pediatrics, National Jewish Health, Denver, Colorado 80206, USA. 8 Department of Medicine, Yale University, New Haven, Connecticut 06510, USA. 9 Department of Laboratory Medicine and Pathology, University of Minnesota, Saint Paul, Minnesota 55108, USA. * These authors contributed equally to this work. Correspondence and requests for materials should be addressed to L.A.O. (email: mailto:[email protected]
Web End [email protected] ).
NATURE COMMUNICATIONS | 6:8472 | DOI: 10.1038/ncomms9472 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications 1
& 2015 Macmillan Publishers Limited. All rights reserved.
DOI: 10.1038/ncomms9472 OPEN
Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms9472
Mesenchymal stem cell (MSC)-based therapies have yielded benecial effects in a broad range of animal models of disease and several human clinical trials.
Nevertheless, their mode of action in vivo remains ambiguous. Early studies indicated that MSCs promoted tissue repair via direct differentiation; however, data showing cells that exhibited transient and low engraftment in vivo rebutted this hypothesis. It is now believed that MSCs achieve a therapeutic effect in vivo via paracrine action13. This paradigm shift was based initially on studies indicating that conditioned medium from cultured MSCs reproduce some of the benecial effects of intact cells4,5. Subsequent studies have identied a long list of paracrine-acting factors secreted by MSCs that contribute to their therapeutic potency13. More recent studies indicate that the cells also shed extracellular vesicles including exosomes (50100 nm in diameter) and microvesicles (MVs; 0.11 mm in diameter) into the extracellular space611 and that MSC-derived exosomes protect mice from myocardial or renal ischaemia, and pulmonary arterial hypertension1215. While the isolation of exosomes requires differential ultracentrifugation, MVs can be isolated from cell culture supernatant by low-speed centrifugation1619. The role of MVs in MSC biology is largely unknown.
MSCs reside within the bone marrow stem cell niche and regulate haematopoietic stem cell (HSC) maintenance via crosstalk with macrophages2025. The bone marrow niche represents a low-oxygen environment, and changes in oxygen concentration affect MSC and HSC fate26,27. We recently reported that culture expansion of MSCs in atmospheric oxygen induces mitochondrial oxidative stress (mtROS) that compromises cell growth and survival28. However, the programme regulating the quality control of mitochondria in MSC is poorly understood. Mitophagy and allophagy regulate mitochondrial numbers in stem cells and mediate the maternal inheritance of mitochondrial DNA (mtDNA) by facilitating the elimination of paternal mitochondria29. Recent studies indicate that mitochondria can be transferred between cells, and cross-talk between MSCs and renal, myocardial and lung epithelial cells involve mitochondrial transfer3032. For example, MSCs introduced into the lungs of lipopolysaccharide (LPS)-treated mice form connexin 43 gap junctional channels and transfer mitochondria to the alveolar epithelium33. However, circulation of mitochondria induces inammatory responses similar to sepsis34. These inammatory responses have been attributed to the release by mitochondria of damage-associated molecular patterns including mtDNA, which stimulate pattern recognition receptors3436. Therefore, while mitochondrial transfer is purported to contribute to the paracrine action of MSCs, its physiological relevance is unclear. Indeed, loss of mitochondria is likely to have detrimental effects on cell survival.
We hypothesized that oxidative stress and mitochondrial dysfunction induce cell survival mechanism in MSCs that include mitochondrial transfer, thereby providing a physiological relevant explanation for this behaviour. To test this hypothesis, we studied mitophagy in MSCs and the role of macrophages in this process since these two cell types are in close proximity within the HSC niche20,24,25. We demonstrate that under standard culture conditions MSCs undergo mitophagy and use arrestin domain-containing protein 1-mediated MVs (ARMMs) to unload mitochondria, which are engulfed by macrophages and re-utilized to increase bioenergetics. Moreover, we show that MSCs tolerize macrophages to mitochondrial transfer by shedding exosomes that modulate Toll-like receptor (TLR) expression and inammatory signalling via transfer of regulatory microRNAs both in vitro and in an in vivo model of lung injury.
ResultsMSCs undergo mitophagy in response to oxidative stress. Human MSCs shed from their surface a diverse subpopulation of vesicles. To characterize these vesicles, we performed electron microscopy on those recovered from MSC-conditioned medium by differential ultracentrifugation (100,000 g for 18 h). This analysis demonstrated the presence of 50100-nm vesicles that are morphologically consistent with exosomes (Fig. 1a, left). Flotation of the 100,000 g pellets on sucrose gradients followed by western blot and uorescent activated cell sorting (FACS) further demonstrated that these vesicles expressed the exosomal markers milk fat globule factor 8 (Mfge8) and the tetraspanins CD9 and CD63, respectively (Supplementary Fig. 1A). Centrifugation of conditioned medium at low speeds (10,000 g) revealed the presence of larger vesicles (4100 nm) that contain subcellular mitochondrial structures including outer and inner membranes and cristae, and expressed the mitochondria-specic protein ATP synthase as evidenced by immuno-gold labelling (Fig. 1a, centre and Supplementary Fig. 1B). MSCs also release larger multivesicular bodies containing lysosome-like vesicles and entire mitochondria, suggesting that these organelles were selected for mitophagy by targeting to autophagosomes (Fig. 1a, right).
To determine whether culture expansion of MSCs impairs mitochondrial function, we expanded cells under physiological oxygen levels (5% O2) or standard culture conditions (21% O2)
and quantied mtROS levels and mitochondrial membrane potential by staining with MitoSOX Red and JC-1, respectively37. FACS analysis of stained cells conrmed that exposure to 21% oxygen resulted in a signicant increase in mtROS (Fig. 1b) and a concomitant decrease in mitochondrial membrane potential as demonstrated by the accumulation of JC-1 monomers (Fig. 1c). Moreover, western blot analysis revealed that prolonged exposure to 21% oxygen activated the Pink1/Parkin-mediated pathway of mitophagy in MSCs but not in human broblasts cultured under identical conditions (Fig. 1d). Herein, increased mitochondrial expression of Parkin and Pink1 kinase was accompanied by Pink1 kinase activation as evidenced by the presence of lower molecular weight moieties of the protein and reduced Miro levels in mitochondrial extracts from P4 versus P1 MSCs (Fig. 1c and Supplementary Fig. 1C). Importantly, Pink1 targets Miro for degradation, thereby severing the connection of the mitochondria to the cytoskeleton and facilitating its incorporation into the phagosome38. Consistent with these results, western blot analysis also revealed that mitochondria-containing MVs expressed microtubule-associated protein 1 light chain 3 (LC3) and autophagy-related protein 12, which are highly enriched in MVs as compared with whole-cell extracts (Supplementary Fig. 1D). Therefore, these MVs are characteristic of autophagosomes39.
MSCs package mitochondria in MVs for cellular transfer. To examine mitophagy in MSCs in more detail, MSCs were infected with baculoviruses encoding green uorescent protein (GFP) fused to the E1alpha pyruvate dehydrogenase leader peptide, which drives transport to the mitochondria, and LC3 fused to a red uorescent protein (RFP) to allow tracking to the phagophore39,40. Fluorescent microscopy conrmed that the GFP-labelled mitochondrial network is in close proximity to RFP-LC3-labelled phagosomes (Fig. 2a). Live cell imaging further revealed that mitochondria are loaded in the cytoplasm into LC3-containing vesicles, which migrate towards the cell periphery and are incorporated into outward budding blebs in the plasma membrane (Fig. 2bd and Supplementary Movie 1). Western blot analysis further revealed that RFP-LC3-MVs also expressed the endosomal sorting complex required for transport (ESCRT)-
2 NATURE COMMUNICATIONS | 6:8472 | DOI: 10.1038/ncomms9472 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms9472 ARTICLE
a
Exosomes (sucrose density 1.091.14)
Multivesicular body
100 nmDirect mag : 80,000
100 nm
Direct mag : 100,000
Mitochondria containing MV
100 nm
Direct mag : 80,000
b
Mitosox high 90
Hypoxia 5%
Normoxia 21%
0 0 102 103 104 105
Mitosox low
PE-A-39.7%
PE-A+60.3%
PE-A+80.1%
P< 0.01
P< 0.01
Count
300
200
100
0 0 102 103 104 105
500
400
300
200
100
PE-A-19.9%
hMSC (%)
80 70 60 50 40 30 20 10
0
5%
Oxygen saturation
21%
MitoSox PE-A
MitoSox PE-A
c
5% 21% Hypoxia Normoxia
5% 21% Hypoxia Normoxia
5% 21% Hypoxia Normoxia
JC-1 monomers/aggregates
75
70
65
60
55
50
hMsC (%)
100
80
60
40
20
0
1
0.8
0.6
0.4
0.2
0
*
*
hMsC (%)
*
JC-1 aggregates
JC-1 monomers
d
hMSC hFibroblasts
P1 P4 P1 P4
Cyt Cyt Cyt Cyt
mt mt mt mt
Parkin
Pink
Miro
Actin
Figure 1 | MSC-derived MVs contain depolarized mitochondria. (a) Left panel, electron microscopy of vesicles isolated from sucrose densities of 1.11 and1.14 g ml 1 and puried using differential ultracentrifugation (100,000g per 18 h) reveal a typical exosome morphology. Middle panel, MVs over 100 nm in size recovered from human MSC-conditioned medium following low-speed (10,000 g per 1 h) centrifugation contain structures conforming to the morphology of mitochondria. Right panel, MVs contain closely packed-vesicles and entire mitochondria (multivesicular body (MVB)) representing autophagosomes. (b) Left panel, ow cytometric analysis of MitoSOX Red-stained human MSCs expanded in 5 or 21% oxygen for 7 days. Right panel, quantication of the ow cytometric data. Plotted values (means.e.m.) represent four replicates for each sample using three distinct replicate cultures from each experimental group. (c) Mitochondrial membrane potential of human MSCs from b determined using JC-1 staining. Expansion in 21% oxygen results in partial depolarization of mitochondria as evidenced by accumulation of JC-1 monomers (*Po0.005, Students-t test versus MSCs in 5% oxygen).
(d) Western blot analysis (Supplementary Fig. 1) of cytoplasmic or mitochondrial extracts prepared from human MSCs expanded in 21% oxygen for the indicated passage numbers (P1 or P4) reveals Parkin mitochondrial translocation and Pink1 kinase activation in human MSCs but not human dermal broblasts. Data are representative of a single experiment repeated ve times.
associated proteins tumour suppressor gene 101 (TSG101) and arrestin domain-containing protein 1 (ARRDC1)11,41 (Supplementary Fig. 1D). Collectively, these results indicate that
MSCs employ the release of ARMMs to extrude mitochondria at their cell surface. Moreover, MSCs exhibited marked increases in apoptosis when treated with Balomycin A1 or low
NATURE COMMUNICATIONS | 6:8472 | DOI: 10.1038/ncomms9472 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications 3
& 2015 Macmillan Publishers Limited. All rights reserved.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms9472
a b c d
e f g h
Figure 2 | MSC outsource mitophagy to macrophages. (ad) Differential interference contrast (DIC) uorescence overlay of live human MSCs expressing uorescent proteins that target mitochondria (green) and phagosomes (red) shows mitochondria being loaded into phagosomes (arrows), which are then shuttled to the plasma membrane for extrusion (also see Supplementary Movie 1). (eh) Inset shows a representative macrophage interacting with a human MSC. This interaction is shown as a time sequence (5 min intervals) in the lower images and in Supplementary Movie 3. The inset demarcates the area in the human MSC plasma membrane where the membrane blebs outwards and accumulates vesicles. Macrophages nibble the surface of human MSCs and uptake mitochondrial laden phagosomes from blebs budding (arrows) from the plasma membrane of the human MSCs. Scale bars, 10 m.
concentrations (35 mM) of chloroquine, which block the mitophagy ux, indicating that this process is critical for MSC survival (Supplementary Movie 2).
Next, we co-cultured GFP-labelled human MSCs from above with primary human or mouse macrophages. Live cell imaging revealed that macrophages nibble the plasma membrane of MSCs, establishing cell contact at areas where membrane blebs are enriched in RFP-labelled vesicles, which are subsequently stripped by the macrophage (Fig. 2eh and Supplementary Movie 3). This activity was also observed between mouse macrophages and primary human MSCs (Fig. 3a and Supplementary Movies 4 and 5) but was not evident when macrophages were co-cultured with mouse or human broblasts (Supplementary Fig. 2). In a subsequent experiment, we co-cultured the macrophage cell line RAW 264.7 with human MSCs containing RFP-labelled mitochondria (10:1 ratio) for 4 h and recovered macrophages using FACS after staining with antibodies that recognize macrophage epitopes (that is, F4/80) not expressed by MSCs. Sorted macrophages were cultured for up to 2 weeks in RPMI media, which do not support MSC expansion and survival. Fluorescent microscopy of these macrophages revealed clear evidence of cell-associated RFP derived from human MSCs (Fig. 3b). To conrm these ndings, we demonstrated using PCR amplication that these macrophages expressed the mitochondrial specic transcript human cytochrome c oxidase I (MT-COX I), which was conrmed on the basis of the restriction fragment pattern obtained after digestion of the PCR product with Bfa1 (Fig. 3b). This PCR product was not detected in mouse macrophages because of limited sequence homology between the two genes30 but was detected in human MSC-derived MVs as expected
(Fig. 3c and Supplementary Fig. 3A). Lastly, we co-cultured Cy5-labelled human MSCs with macrophages that were pre-incubated with or without dextran sulfate (100 mg ml 1), a nonspecic inhibitor of phagocytosis. Live cell imaging showed phagocytosis of MVs by macrophages over a period of 18 min, and confocal microscopy conrmed that the engulfed Cy5-labelled vesicles resided within the cell body of the macrophage (Supplementary Movie 6). However, MV uptake was blocked in macrophages pre-treated with dextran sulfate as evidenced by the accumulation of Cy5-labelled MVs on the macrophage surface (Supplementary Movie 7).
To track the in vivo transfer of mitochondria, we systemically administered RFP-labelled human MSCs into C57BL/6 mice expressing a GFP reporter under control of the endothelial specic Tie2 promoter. At 24 h post injection, GFP-labelled endothelial cells, epithelial cells and macrophages that contained RFP-labelled mitochondria were visible (Supplementary Fig. 3B). Bfa1 digestion of mouse lung DNA following intravenous administration of human MSCs, exosomes or MVs yielded a pattern of restriction similar to those observed in RAW 264.7 macrophages (Fig. 3d). To follow the fate of viable human MSCs in the mouse lung, we measured the abundance of human-specic GAPDH transcripts via reverse transcriptasePCR (RTPCR)42. Human GAPDH mRNA was not detected in the lung tissue of untreated mice but was detected at 3 days post injection of human MSCs or human broblasts (Fig. 3d). However, expression rapidly declined and was no longer evident by 14 or 28 days post transplant, consistent with the clearance rate of cells from lung tissue. Expression of human COXI mRNA in mouse lung mirrored that of human GAPDH following injection of human
4 NATURE COMMUNICATIONS | 6:8472 | DOI: 10.1038/ncomms9472 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms9472 ARTICLE
a
b
Maker
hMSC
hMSC/Bfa I
RAW
RAW/hMSC
RAW/hMSC/Bfa I
Human cytochrome oxidase l
Microvesicles
a b
c d
c
Maker
RAW 264.7
Exosomes
hMSC
DNA
Microvesicles
Maker
Bfa I
DNA Bfa I
00:00
44:00
112:00
200 bp 200 bp
90:00
d
hMSC
Exosomes
hGAPDH hCOX I
14
12 10
8 6 4 2 0
12 10
8 6 4 2 0
Untreated
Microvesicles
*
Fold increase (2C T)
Untreated
D3 D14 D28
C57BI/6 si HMSCs IT HMSCs IV Exo IT Exo IV Fibro IV
*
#
BfaI-digested C57BL/6 lung
Untreated
D3 D14 D28
Figure 3 | MSC transfer mitochondria to macrophages and lung tissues. (a) Top panel is DIC uorescent overlay at time 0 of primary human MSCs infected with Organelle Lights to label mitochondria (green) and co-cultured with mouse (RAW 264.7) macrophages. Lower panels, time sequence at 45 min intervals showing transfer of green-labelled mitochondria from the a MSC to a macrophage (red arrow, see Supplementary Movie 4 for transfer of mitochondria in lamentous form, and Supplementary Movie 5 in which GFP signal is compensated to allow the tracking of the transferred mitochondria into macrophages). (b) Left panel, photomicrograph of FACS-sorted mouse macrophages that were co-cultured with mitochondria-labelled (RFP) human MSCs clearly show retention of RFP label. Right panel, electrophoretic pattern of human COX I PCR product treated with or without Bfa1 after amplication from the indicated cell sources. (c) MSC-derived exosomes and MVs express the Bfa1-sensitive 228-bp COX I mtDNA PCR product detected in human MSCs (b). (d) Left panel, electrophoretic pattern of Bfa1-digested human COX1 PCR product amplied from mouse lung DNA isolated 14 days after the intravenous administration of human MSCs, human MSC-derived MVs or exosomes. Right panel, human GAPDH and human COX1 relative expression levels quantied by RTPCR in mouse lung (328 days) after a single (intratracheal (IT) or intravenous (IV)) injection of human MSCs, human MSC-derived exosomes or human broblasts. *Po0.001, #Po0.001 by ANOVA compared with untreated mouse lung. Plotted values (means.e.m.) are from experiments repeated four times. Scale bars, 20 m.
broblasts and was detected at 3 days but not 14 or 28 days post transplant. In contrast, human COXI transcripts were detected up to 28 days post injection of human MSCs, indicating that mouse lung tissue retained mtDNA long after the disappearance of viable human MSCs (Fig. 3d). Thus, MSC-derived vesicles constitute an effective mechanism to transfer mtDNA into the mouse lung.
MSC extracellular vesicles enhance macrophage energetics. To study the effect of MVs on macrophage bioenergetics, we
analysed oxygen consumption rates (OCRs) using the SeaHorse technology. Human macrophages exhibit higher basal OCR than human MSCs or human broblasts (Fig. 4a). Co-culture of macrophages with human MSCs (Mac hMSC) or MSC-derived
exosomes (Mac Exo) but not human broblasts (Mac Fibro)
signicantly (analysis of variance (ANOVA) followed by StudentNeuman Keuls (SNK) post-hoc pairwise comparisons) increased their OCR, suggesting that MSCs or MSC-derived exosomes alter macrophage bioenergetics (Fig. 4a). Next, we repeated these measurements after treatment of cells with
NATURE COMMUNICATIONS | 6:8472 | DOI: 10.1038/ncomms9472 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications 5
& 2015 Macmillan Publishers Limited. All rights reserved.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms9472
a
200
180
* *
Oxygen consumption rate
(pmol min2 per 2 104 cells)
160
140
*
120
*
100
80
60
40
20
* *
0
Baseline Proton leak FCCP (uncoupled)
Macrophages
hMSCs
hFibroblasts
Macrophages + Fibro
Macrophages + hMSCs
Macrophages + Exo
b c
0.5
0.45
Baseline
120 min 240 min
Silca Silca/exosomes
0.4
Non-silica treated Silica/exo Silica
0.35
0.3
0
0.25
0.2
0.15
MitoSox red emission intensity
(relative to baseline)
50 m
0.1
0.05
0.05
0 20 40 60 80 100 120 140 160 180 200 220 240
0.1
0.5
Time following silica exposure (min)
Non-silica treated
0.45
0.4
0.35
0.3
0.25
0.2
0.15
0.1
Human macrophages
0.05
0
d
0.05
0
20 40 60 80 100 120 140 160 180 200 220 240
Oxygen consumption rate
(pmol min2 per 1 106 cells)
0.1
Time following silica exposure (min)
* #
140 120 100
80 60 40 20
0 CTR Mac hMSC
*
*
hFib Exo
Silica exposed macrophages
Figure 4 | MSCs enhance macrophage bioenergetics. (a) Mitochondrial respiration of human macrophages, human MSCs or human broblasts was measured as OCR using the XF technology. Macrophages were co-cultured with or without human MSCs or broblasts (1:10 ratio) or treated with human MSC-derived exosomes (40 mg per protein) in the presence or absence of Oligomycin A and FCCP to differentiate ATP-linked respiration from the proton leak. Plotted data (means.e.m.) were performed using six replicates per sample and repeated three times. (b) Pseudocoloured photomicrographs (0240 min) of MitoSOX Red-stained macrophages that were non-stimulated (upper panel), or treated with silica (20 mg cm 2, lower panel) or silica plus human MSC-derived exosomes (added 10 min after silica, middle panel). Scale bars, 50 m. (c) Time course of MitoSOX Red emission by human macrophages treated as in b. Figure is representative of ve exposures (nine stages positions per test and 6 cells per stage). (d) OCR as in a of silica-exposed macrophages treated with or without human MSCs, human MSC-derived exosomes or human broblasts. Plotted values (means.e.m.) are from experiments repeated three times, *Po0.05 as compared to control, #Po0.05 as compared to silica treated macrophages, as determined by
Students t-test.
oligomycin A, an inhibitor of ATP synthase, which is required for the oxidative phosphorylation of ADP to ATP. These conditions differentiate ATP-linked respiration from the proton leak. Macrophages exhibited a higher level of proton leak as compared with human MSCs and broblasts, and proton leak was signicantly (ANOVA followed by SNK post hoc pairwise comparisons) reduced following co-culture with human Mac Exo but
not Mac Fibro (Fig. 4a). Co-culture with human MSCs
(Mac hMSC) also signicantly (ANOVA followed by SNK post
hoc pairwise comparisons) reduced proton leak in macrophages. We also repeated the OCR measurements following treatment of cells with the uncoupling agent carbonyl cyanide 4-(triuoromethoxy) phenylhydraone (FCCP) to determine how
cells respond to an increase in ATP demand. All three cell types responded to FCCP treatment with increased OCR, and the magnitude of the response was greater in macrophages as compared with human MSCs and broblasts. Moreover, OCR was signicantly increased in FCCP-treated macrophages following co-culture with human MSCs (Mac hMSC) or human
Mac Exo but not Mac Fibro (Fig. 4a).
To examine the effect of MSC or exosomes on macrophage bioenergetics under conditions of altered homeostasis, we exposed macrophages to silica particles. Silica exposure results in a burst of mtROS production as evidenced by changes in MitoSOX Red uorescence intensity; however, this effect is largely mitigated in macrophages incubated with human
6 NATURE COMMUNICATIONS | 6:8472 | DOI: 10.1038/ncomms9472 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms9472 ARTICLE
MSC-derived exosomes (Fig. 4b,c). Silica exposure also decreased macrophage OCR, but this decrease was reversed by co-culture with human MSCs or human MSC-derived exosomes but not with human broblasts (Fig. 4d). The fact that transfer of partially depolarized mitochondria from MSCs to macrophages enhances that macrophage bioenergetics appears paradoxical. However, loss of mitochondrial membrane potential as a result of MSC expansion is not absolute as mitochondria exhibit residual membrane potential as evidenced by the concentration of JC-1 aggregates (Fig. 1c). This indicates that the mitochondrial membrane is not collapsed and the mitochondria are still capable of undergoing fusion. To determine whether these mitochondria are recycled in macrophages by fusion, we co-cultured human MSCs with macrophages after labelling cells with two different MitoTracker dyes (Red and Green)43. Live cell imaging clearly demonstrated the transfer and subsequent fusion (yellow colour in merged images) of RFP-labelled, human MSC-derived mitochondria with GFP-labelled mitochondria within human macrophages (Fig. 5). These data indicate that under oxidative stress MSCs outsource mitophagy to macrophages to unload partially depolarized mitochondria, which are recycled via fusion by macrophages thereby enhancing their bioenergetics.
MSC-derived exosomes are enriched in microRNAs. Exosomes transfer RNAs between cells8. We hypothesized that this process may be exploited by MSCs to tolerize macrophages against mitochondrial transfer. To explore this possibility, we analysed the RNA content of human MSC-derived exosomes. Using microRNA microarray analysis, we identied 156 (45 increased; 111 decreased) microRNAs that differed (log241.0, Po0.05 (ANOVA followed by HolmSidak post hoc pairwise
comparisons) in abundance between exosomes compared with their parent MSCs. The 10 microRNAs that exhibited the greatest increase included miR451a (316-fold), miR1202 (45-fold), miR630 (40-fold) and miR638 (28-fold), while microRNAs that exhibited the greatest decrease in exosomes and were enriched in MSCs included miR125b (148-fold) and miR21 (91-fold; Fig. 6a,b). This pattern of microRNA expression was conserved in MSC-derived exosomes obtained from ve human donors (Fig. 6c,d).
MSC-derived exosomes inhibit TLR signalling in macrophages.
Mitochondrial uptake can induce inammation via activation of pattern recognition receptors34. Therefore, given the presence of mtDNA and microRNAs in MSC-derived MVs and exosomes, respectively, we hypothesized that exposure to these vesicles would tolerize macrophages to mitochondrial transfer by inducing changes in TLR expression. Subsequently, we proled the expression of 84 TLR-associated transcripts in mouse macrophages. We contrasted these results with those observed in macrophages that were co-cultured with mouse or human MSCs, human MSC-derived exosomes or silica particles, which when phagocytized induce macrophage activation44. Co-culture of macrophages with MSC-derived exosomes induced nuclear translocation of the transcription factor NF-kB (Fig. 7a) resulting in signicant changes (42.5-fold increase or decrease) in expression of 50 of the 84 TLR-associated transcripts (Fig. 7b). For example, compared with silica-exposed macrophages those treated with exosomes exhibited signicant (42.5-fold)
increases in transcripts associated with cytokine signalling including interleukin (IL)-1b, prostaglandin endoperoxide synthase 2 (PTGS2, aka COX2), granulocyte colony-stimulating
a b c
d e f
g h i
j k l
Figure 5 | Mitochondrial transfer from human MSCs is followed by fusion inside macrophages. Human MSCs and human macrophages (1 105) were
infected separately with Organelle Lights to label human MSC mitochondria (red) and macrophage mitochondria (green). Twenty-four hours following infection, macrophages were harvested and co-incubated with the human MSCs for 2 h. Images were collected using an inverted Nikon TiE uorescent microscope equipped with a 60 oil immersion optic and NIS Elements Software. Organelle Lights were excited using a Lumencor diode-pumped light
engine and detected using an ORCA-Flash4.0 sCMOS camera. (a,b) DIC images of two separate elds within the same dish. (c) A zoomed image of the outlined section within b (scale bars, 20 m). The uorescence-based images for each eld appear in the panels below the DIC images, with df showing macrophage mitochondria (green); gi showing human MSC mitochondria (red); and jl showing the overlay with yellow indicative of colocalization of human MSC and macrophage mitochondria. Not every macrophage was shown to take up human MSC mitochondria (a,d,g, j).
NATURE COMMUNICATIONS | 6:8472 | DOI: 10.1038/ncomms9472 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications 7
& 2015 Macmillan Publishers Limited. All rights reserved.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms9472
a
b
Human MSCs Exosomes
1 2 3 4 5 2 3 4 5
1
miR-451 miR-1,202 miR-630
miR-1,2075p miR-33b*
miR-K123 miR-1,268 miR-638 miR-575 miR-1,2255p miR-29a miR-24 miR-23a let-7flet-7i miR-125b miR-100 miR-23b let-7c
miR-27b
Fold enrichment (log 2)
8
6
4
2
0
miR-451
miR-1,202
miR-638
miR-630
miR-1,2255p
miR-1,2075p
miR-1,268
miR-33b*
miR-575
miR-940
miR-1,308
miR-1,228
miR-1,234
miR-1,915
miR-1,238
miR-191*
miR-223 miR-1885p
miR-939
miR-1,825 miR-1,2245p
miR-1,246
miR-1,280
miR-1,281
miR-425*
miR-1423p
miR-1293p
miR-766
miR-1,237
miR-634
miR-181d
miR-1,539
miR-595
miR-933
miR-664
miR-877*
miR-1,229
miR-149
miR-320c
MicroRNA
c d
6 4 2 0 2 4
6 4 2 0 2 4
6 4 2 0 2 4
6 4 2 0 2 4
Log10 (corrected Pvalue)
4
3.5
3
2.5
2
6 4 2 0 2 4
8 6 4 2 0 2
Log2 (fold change)
4 6 8
6 4 2 0 2 4
Figure 6 | RNA expression prole in human MSCs and their exosomes. (a) Heatmap illustrating the 10 microRNAs most highly enriched in human MSCs versus their corresponding exosomes. Every row represents a microRNA and every column a cell or exosome, and yellow and purple represent increased or decreased expression, respectively. (b) Plotted values represent the means log 2 fold enrichment of exosomal versus human MSC microRNAs (n 5 microarrays of different MSCs cell lines; Po0.05, ANOVA followed by HolmSidak post hoc pairwise comparisons). (c) Data in b show distribution of
differentially expressed microRNAs between samples based on the log base 10 signicant P value (o0.05) and with a relative fold change of 42 (in log base 2). Green and red squares represent increasingly and decreasingly expressed microRNAs, respectively, in exosomes versus human MSCs.
(d) Computational analysis of human MSCs and exosomes from ve donors demonstrates that microRNAs isolated in exosomes cluster among different donors.
factor 3 (CSF3), IL-10, chemokine (CC motif) ligand 2 (CCL2, aka MCP-1), NF-kB-chemokine (CXC motif) ligand 10 (CXCL10), tumour necrosis factor (TNF) and reticuloendotheliosis oncogene (Rel; Fig. 7b). In contrast, transcripts encoding proteins involved in MyD88-dependent signalling (MyD88, TLR 1,4,5,7,8 and 9, IRAK1 and TRAF6), TRIF-dependent signalling (TLR adaptor molecule 1 (TICAM1) and TICAM2) and TLR-related signalling (CD80, CD86, IL-2, IL-12, Interferon gamma, PGLYRP1 and CSF2) were downregulated.
MSCs secrete PGE2 that acts on prostaglandin receptors of LPS-stimulated macrophages to enhance their production of the anti-inammatory cytokine IL-10 (ref. 45). However, this effect of MSCs was abrogated in macrophages from TLR4, MyD88, TNFR1 or COX2-decient mice45. Consistent with these results, exosome treatment of non-stimulated macrophages augmented secretion of PGE2, TNF, IL-10 and IL-1-receptor antagonist (Fig. 7c), which may reprogramme macrophages3. These responses recapitulate those observed when macrophages are exposed to intact human or mouse MSCs, except that IL-6, CSF2
and IL-1 receptor 1 were increased more following exposure to mouse MSCs (Fig. 7b).
Subsequently, we treated TLR-signalling-decient macrophages (TLR4 / , TLR9 / , MyD88 / ) or scavenger receptor-decient macrophages (MARCO / ) with MSC-derived exosomes. As shown in Fig. 7c, PGE2 production was similar following exosome treatment in all signalling-decient macrophages as compared with wild-type cells from strain-matched C57BL/6J or BALB/CJ mice. In contrast, secretion of TNF and IL-10 was signicantly (ANOVA followed by SNK post hoc pairwise comparisons) reduced in TLR4 / and
MYD88 / macrophages as compared with wild-type cells following exosome treatment, and IL-10 secretion was also signicantly reduced in macrophages from TLR9 / mice (Fig. 7c). These data conrm the importance of TLRs and in particular MyD88-dependent pathways in mediating exosome-induced effects on macrophage function. Lastly, we showed that pre-incubation with dextran sulfate signicantly (ANOVA followed by SNK post hoc pairwise comparisons)
8 NATURE COMMUNICATIONS | 6:8472 | DOI: 10.1038/ncomms9472 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms9472 ARTICLE
a b c
Untreated
Exosomes
Silica
hMSC
mMSC
Exosomes
PGE 2
Symbol IL1B
RIPK2 CSF3 PTGS2 IL10
TNF NFKB1 NFKB2 TLR6 CCL2 CLEC4E REL CXC10
NFKBIB FOS IL1A
TNFAIP3
TLR2 MAP2K3
LTA NFKBIA MAPK8 CEBPB ELK1 TIRAP TLR3
CD14 RELA TNFRSF1A CD80 TLR9 MAP3K1 CSF2 IL1R1 GUSB TLR1
CD86 TLR8 TLR7 TICAM2 TLR4 FADD PGLYRP1 IL6 PPARA IFNG MUC13 IL12AIL2TLR5
RAW 264.7
MARCO/
TLR9/ TLR4/
MYD88/
BALB/c
C57BL/6
RAW 264.7 MARCO/
TLR9/
TLR4/ MYD88/
BALB/c
C57BL/6
pg ml1
Exosomes 6 h
Exosomes 4 h
Exosomes 2 h
Baseline
pg ml1
RAW 264.7
0
0
1,000
NF-B
2,000
3,000
4,000
TNF
15 m
RAW 264.7 macrophages
d
Silica
BSL
TLR7
Actin
MyD88 *
**
*
Silica/exosomes
1 h 2 h 4 h 6 h 1 h 2 h 4 h 6 h
*
pg ml1
100 200 300 400 500
IL-10
#
MARCO/
TLR9/ TLR4/ MYD88/
BALB/c
C57BL/6
TLR9
#
TLR7
TLR4
TNF
Exosomes Exosomes/Indo
DICER/ exosomes DICER/ exosomes/Indo
*
*
#
0 50 100 150 200 250 300
#
*
3 2 1 0 1 2 3
Fold change expression (CT)
Figure 7 | MSC-derived MVs inhibit TLR signalling in macrophages. (a) Upper panels, confocal microscopy showing intracellular localization of Cy5-labelled exosomes within macrophages 18 min post administration. Lower panel, nuclear localization of NF-kB in macrophages 2 h post administration of exosomes. Scale bars, 15 m. (b) Partial heatmap illustrating mRNA levels of 84 TLR-associated transcripts in macrophages at 8 h post treatment with silica (20 mg cm 2), human or mouse MSCs (1:10 ratio) or human MSC-derived exosomes (40 mg protein). Transcript order is highest (top) to lowest (bottom), and each row represents a gene and each column a specic treatment. Red and green illustrates increased or decreased gene expression, respectively.
Experiments were repeated four times. (c) Effect of exosome treatment on PGE2, TNF and IL-10 secretion in macrophages from the indicated mouse strains. Plotted data (means.e.m.) were from experiments repeated ve times. *Po0.05 compared with C57BL/6J or BALB/CJ macrophages as determined by ANOVA). (d) Upper panel, western blot illustrating the time-dependent effect of silica or human MSC-derived exosomes on expression of
TLR7 in macrophages. Lower panel, fold change in expression of the indicated transcripts in macrophages RTPCR demonstrating the negative regulation of exosomes on macrophage expression of TLR genes. Plotted data (means.e.m.) are from experiments repeated four times. *Po0.05 compared with baseline. #Po0.05 compared with native exosomes by Student t-test. wPo0.05 compared with the effect of native exosomes and indomethacin (Indo)
treated by Students t-test.
reduced the release of PGE2, TNF and IL-10 by exosome-treated macrophages, conrming the need for phagocytosis of MSC-derived vesicles in this process (Supplementary Fig. 4A).
To examine the role of microRNAs in macrophage tolerization, we treated RAW 264.7 cells, which use TLRs to recruit autophagy proteins in phagosomes to degrade its cargo46, with exosomes derived from human MSCs transfected with or without an short-hairpin RNA (shRNA) designed to inhibit DICER expression in the presence or absence of indomethacin, a cyclooxygenase inhibitor (Supplementary Fig. 4B). Treatment of naive RAW 264.7 macrophages with native exosomes enhanced
TNF and reduced TLRs and MyD88 mRNA expression over 24 h (Fig. 7c), while treatment of silica-exposed macrophages with exosomes ameliorated TLR7 induction following silica exposure (Fig. 7c). Pre-incubation of RAW 264.7 macrophages with indomethacin before treatment with native exosomes, or treatment with exosomes from DICER knockout MSCs signicantly (ANOVA followed by SNK post hoc pairwise comparisons) reduced the observed effects on TLR mRNA expression (Fig. 7c) and reduced secretion of proteins such as TNF, MIP, MCP1, KC and IP-10 associated with macrophage activation (Supplementary Fig. 4B,C). The inhibitory effects of
NATURE COMMUNICATIONS | 6:8472 | DOI: 10.1038/ncomms9472 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications 9
& 2015 Macmillan Publishers Limited. All rights reserved.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms9472
indomethacin were restricted to TLR4 and MyD88 mRNA, while the effects of DICER-decient exosomes were of greater magnitude and also involved negative regulation of TLR 7 and 9 (Fig. 7c). Concomitant treatment with indomethacin and exosomes from DICER-decient exosomes demonstrated additive effects (Fig. 7c).
Importantly, miR-451 is one of the most abundantly expressed microRNAs in MSC-derived exosomes, but its maturation occurs independent of DICER47. Therefore, its expression is not altered in exosomes from DICER knockdown MSCs. MiR-451 negatively regulates cytokine production in dendritic cells infected with inuenza virus48. Consistent with these results, transfection of RAW 264.7 macrophages with a miR-451 mimic signicantly (Students t-test) decreased TNF mRNA expression in non-stimulated macrophages, and inhibited mRNA expression and protein release in silica-exposed macrophages (Supplementary Fig. 4D). In contrast, treatment of cells with a miR-451 antagomir yielded the opposite result. These data conrm a role of exosome-derived microRNAs in regulating cytokine expression in macrophages.
MSC exosomes attenuate monocyte activation and silicosis. Circulating MVs enter the bone marrow and reprogramme cells to express proteins of the tissue of vesicle origin49. Ly6Chi monocytes are recruited from the bone marrow into the lung in response to injury and play an important role in the pathogenesis of lung brosis50,51. Therefore, we investigated whether MSC or their exosomes are capable of altering the lung recruitment and cytokine production of Ly6Chi monocytes in mice following silica exposure. As shown in Fig. 8a, FACS identied a limited number of Ly6Chi monocytes in the normal mouse lung, which was signicantly (ANOVA followed by SNK post hoc pairwise comparisons) increased by 72 h post exposure to silica. Moreover, high expression of CCR2 and release of inammatory (TNF, CCL2 and CXCL1) and brotic (transforming growth factor b (TGFb)
and IL-10) mediators indicate that these monocytes are activated (Fig. 8b). In contrast, intravenous administration of human MSCs (500,000 cells) or freshly isolated human MSC-derived exosomes (B3 1011 exosomes containing 40 mg protein) at 24 h post-silica
exposure (0.2 g kg 1) signicantly reduced the extent of Ly6Chi
monocyte inltration into the lung and secreted levels of inammatory mediators (Fig. 8a,b).
Silica induces inammation and collagen deposition in peribronchiolar, silicotic nodule and peri-vascular regions of the lung (Fig. 9a). These lesions are associated with enhanced numbers of inammatory cells (although the percentage of macrophages decreases, there is an increase in neutrophils and lymphocytes) in bronchoalveolar lavage uid (BALF, Fig. 9b), signicant deposition of lung collagen as measured by hydroxyproline (Fig. 9c) and enhanced expression of pro-inammatory cytokines (TNF and IL-6) and brotic mediators (IL-10 and a(I) collagen) by 14 and 28 days after silica exposure (Fig. 9d). Intravenous administration of human MSCs or exosomes 3 days after silica exposure reduced the size of the silicotic nodules (Fig. 9a), the total number of white blood cells in BALF (Fig. 9b) and expression of inammatory and pro-brotic genes in the lung (Fig. 9d). Administration of exosomes signicantly (ANOVA followed by SNK post hoc pairwise comparisons) reduced the accumulation of neutrophils and lymphocytes in BALF, while MSCs only reduced the accumulation of neutrophils and induced a slight (o1%)
increase in eosinophil count (Fig. 9b). In contrast, the intravenous administration of human broblasts signicantly exacerbated the inammatory and brotic responses to silica (Fig. 9ac). Exosomes, but not MSC or broblast administration, reduced the accumulation of hydroxyproline in lung tissue 28 days after silica (Fig. 9c).
DiscussionMSCs modulate macrophage function by a variety of mechanisms, and this crosstalk contributes to their anti-inammatory activity but the physiological relevance of this crosstalk remains obscure particularly as it relates to the survival and function of MSCs. In this study, we report that during their ex vivo culture MSCs transfer partially depolarized mitochondria to macrophages as a pro-survival mechanism in response to oxidative stress and that these mitochondria are repurposed via a process involving fusion to increase macrophage bioenergetics. Moreover, we show that MSCs also desensitize macrophages to mitochondrial transfers by repressing TLR-signalling. Our data indicate that MSCs employ two different types of MVs to achieve these goals. MSCs load mitochondria in the cytoplasm into LC3 containing MVs that are recovered from cell culture media with low-speed centrifugation. These MVs express the ESCRT-I-associated proteins TSG101 and ARRDC1 and are extruded from cells in ARMMs11, which bud outwards directly from the plasma membrane where they are identied by macrophages. MSCs also shed exosomes that modulate TLR signalling and cytokine secretion in macrophages, in part, by transfer of regulatory microRNAs.
Previous reports indicate that mitochondria transferred by MSCs improve the energetic activity of the alveolar epithelium of LPS-treated mice3033 and animal models of rotenone-induced airway injury52. However, the benecial effects of mitochondria were limited to acceptor cells almost completely decient of mitochondrial function30,53. Therefore, it is unclear whether rescue is because of the transfer of mitochondria, mtDNA or release of other mediators by MSCs33. Importantly, the bone marrow niche contains few, if any, epithelium, so the physiological relevance of this is unclear.
Our data suggest that mitochondrial transfer by MSCs is not altruistic but rather may serve to enhance MSCs cell survival by unloading partially depolarized mitochondria. Elimination of depolarized mitochondria is a priority for MSCs that experience high mtROS generation when cultured under atmospheric oxygen tension28 since inhibitors of the mitophagy ux induce MSC apoptosis. Unexpectedly, MV-mediated mitochondrial transfer augments macrophage function by improving mitochondrial bioenergetics. As reported for the alveolar epithelial cells, recovery of the energetic function of macrophages is characterized by an increased ability to generate ATP under conditions in which the cells exhibit mitochondrial uncoupling or an enhanced proton leak, and involves protection of the macrophage by reducing mtROS generation. This outcome is consistent with data indicating that transfer of mitochondria, even if partially depolarized, is followed by fusion inside the acceptor macrophage. Notably, several studies have reported that transfer of only a few mitochondria is sufcient to rescue cells depleted of mtDNA by culture in ethidium bromide30,54,55. Furthermore, the current study conrms evidence that exosomes, which do not carry mitochondria, contain nucleic acids56, including mtDNA that can be transferred, long term, in vivo to the lung. Presence of mtDNA inside exosomes is not surprising as mtDNAs are dispersed throughout the mitochondrial network as histone-free nucleoids with an average size in mammals under 100 nm, and contain a single copy of mtDNA per nucleoid57. However, we cannot completely exclude the possibility that the exosome preparations could be contaminated by apoptotic bodies.
Accumulation of mtDNA that escapes mitophagy induces TLR 9-mediated inammation that in the case of cardiac muscle is associated with heart failure35 and mice transplanted with cells harbouring allogeneic mtDNA trigger MyD88 responses to reject these cells36. Therefore, silencing TLR responses in macrophages is likely necessary to induce tolerance to transferred
10 NATURE COMMUNICATIONS | 6:8472 | DOI: 10.1038/ncomms9472 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms9472 ARTICLE
a
*
Cells per lung (absolute numbers)
18,000
16,000
14,000
12,000
10,000
8,000
6,000
4,000
2,000
b
800
600
400
200
0
30
25
20
15
10
5
0
8,000 7,000 6,000 5,000 4,000 3,000 2,000 1,000
0
250
200
150
100
50
0
21.81.61.41.2 1
0.80.60.40.2 0
#
Control
Silica
Silica/Exo
Silica/hMSC
*
TGF
TGF
MCP-1
#
0 F4/80Cd11b Ly6C-CCR2+
105
104
103
102
105
104
103
102
105
104
103
102
105
104
103
102
3%
19.6%
6.4%
78%
93%
95.5%
pg ml1 (104 cells)
*
105
104
103
102
105
104
103
102
105
104
103
102
105
104
103
102
Control
15
10
5
0
P5
#
102 103 104 105 102 103 104 105 102 103 104 105
102 103 104 105 102 103 104 105 102 103 104 105
102 103 104 105 102 103 104 105 102 103 104 105
102 103 104 105 102 103 104 105 102 103 104 105
40 35 30 25 20 15 10
5 0
*
Silica
2,000
1,500
1,000
500
0
2,000
1,500
1,000
500
0
P5
#
CD11V450b
*
KC
IL-10
#
#
Silica/Exo
P5
P5
*
8% 92%
Silica/hMSC
Cytokine release
F4/80
LY6C CCR2
Figure 8 | Human MSCs and their exosomes prevent the accumulation of Ly6Chi monocytes in the lungs of silica-exposed mice. (a) Upper panel, absolute number of F4/80/CD11b- and Ly6C/CCR2-expressing cells in lung tissue of mice 72 h post administration of saline (50 ml), silica (0.2 g kg 1) or silica plus human MSC-derived exosomes (B3 1011 exosomes containing 40 mg protein). *Po0.05 compared with saline by t-test). Lower panel,
representative histograms of ow cytometric data analysed in a showing the phenotype and frequency of cells recovered from lung tissue after enzymatic digestion. (b) Mulitplex ELISA of inammatory (TNF, MCP1 and KC) and brotic (TGFb and IL-10) mediators secreted by cultured F4/80/CD11b/ and
Ly6C/CCR2 cells from a. Plotted values (means.e.m.) are from experiments using N 5 animals per group and repeated three times. *Po0.05 compared
with saline, #Po0.001 compared with silica-treated monocytes by ANOVA.
NATURE COMMUNICATIONS | 6:8472 | DOI: 10.1038/ncomms9472 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications 11
& 2015 Macmillan Publishers Limited. All rights reserved.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms9472
a
Control Silica Silica hMSC IV Silica exosomes IV Silica hFib IVPleura Pleura
Pleura
b
100
80 60 40 20
0
40 35 30 25 20 15 10
5 0
* *
*
7
6
5
4
3
2
1
* * *
% neutrophils
% eosinophils
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.10
*
*
Total cells (10 106 )
% lymphocytes% macrophages
*
*
25 20 15 10
5 0
*
*
#
*
*
* * *
Control Silica Silica/hMSC Silica/exo Silica/hFib
Control Silica Silica/hMSC Silica/exo Silica/hFib
c d
180
150
120
90
60
30
*
*
* *
Collagen l1
Fold increase in gene expression
Hydroxyproline (g)
25 20 15 10
5
120 100
80 60 40 20
*
*
TNF
* *
* *
*
*
* *
*
D14 D28 D14 D28
D14 D28
160
140
120
100
80
60
40
20
*
*
*
30 25 20 15 10
5
IL-6 IL-10
*
*
* *
*
*
* *
*
D14 D28
Figure 9 | Human MSCs and their exosomes ameliorate experimental silicosis. (a) Photomicrographs of lung sections stained with haematoxylin and eosine from mice 28 days after intratracheal administration of silica (0.2 g kg 1) alone or followed 3 days later with an intravenous injection of human
MSCs, human MSC-derived exosomes (B3 1011 exosomes containing 40 mg protein) or human broblasts (scale bars, 500 m). (b) Upper panel,
photomicrographs of Diff-Quick-stained cytospins of BAL from mice in a. Lower panel, differential cell counts showing counts of total cells (left) and percentage of macrophages, lymphocytes, neutrophils and eosinophils (right panels). *Po0.05 compared with control, wPo0.05 compared with broblasts treated mice by Students t-test. (c) Hydroxyproline content of lung tissue from animals treated as in a. *Po0.001 compared with saline by Students t-test. wPo0.05 compared with silica, human MSC or broblast by ANOVA. (d) Quantication of mouse TNF, IL-6, IL-10 and Col1a1 levels in lung tissue from mice in a at 14 and 28 d post treatment. Plotted values (means.e.m.) are representative of experiments using 15 animals per group and repeated three times.
*Po0.001 compared with saline by Students t-test, wPo0.05 compared with silica by ANOVA.
mitochondria. Consistent with this hypothesis, we demonstrate that uptake of MSC-derived exosomes represses TLR signalling in macrophages and the production of inammatory mediators by targeting pathways (TLRs and NF-kB) central to inammation.
Interestingly, microRNAs present in MSC-derived exosomes are highly conserved between human MSC donors. One such microRNA, miR-451, is highly abundant in exosomes but is expressed at low levels in macrophages and dendritic cells where it regulates cytokine production5860. Mir-451 is known to suppress TNF, and macrophage migration inhibitory factor,
which inhibits the anti-inammatory effects of glucocorticoids and negatively regulates p38 MAPK signalling to protect from diabetic nephropathy48,5860. Indeed, ectopic expression of a mir-451 mimic in macrophages inhibits TNF secretion in response to silica. Consistent with these ndings, MSC-derived exosomes prevent the recruitment of Ly6Chi monocytes and reduces secretion of pro-brotic IL-10 and TGFb by these cells in the lung of silica-exposed mice. Therefore, these data suggest that, as tested in vitro, immunomodulatory activities may have evolved, in part, as a mechanism by which MSCs survive oxidative stress
12 NATURE COMMUNICATIONS | 6:8472 | DOI: 10.1038/ncomms9472 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms9472 ARTICLE
and serendipitously confers on cells the ability to suppress inammation, in lung injury models. Indeed, our data illustrate a physiological role for the innate immune regulatory activity of MSCs, and in doing so further highlights the important association between MSCs and macrophages in vivo.
Methods
Human MSC and cell lines. Human MSCs were harvested from small volume aspirates of the iliac crest bone marrow from ve healthy adult volunteers by the Center for Preparation and Distribution of Adult Stem Cells formerly at the Tulane University School of Medicine (New Orleans, LA). The Institutional Review Board at the Tulane University approved the procedures involved in the procurement of these cells as previously described61. Human MSCs were also provided by the National Heart Lung and Blood Institute (NHLBI)-sponsored Production Assistance for Cellular Therapies Program at the University of Minnesota. Adult normal human dermal or lung broblasts were commercially obtained from Lonza (Walkersville, MD). Mouse MSCs were isolated from FVB/NJ or C57BL/6J mice (The Jackson Laboratory) as previously described28. All studies employing human or mouse MSCs were performed using low-passage (14) populations. Primary mouse macrophages were isolated from the femurs of C57BL/6J, BALB/CJ (The Jackson Laboratory), TLR4 / (The Jackson Laboratory), TLR9 / and MyD88 / (Department
of Host Defense, Research Institute for Microbial Diseases, Osaka University and Core Research for Evolutional Science and Technology, Japan Science and Technology Corporation, Suita) and MARCO / (provided by Dr Andrij Holian
at the University of Montana) strains as previously reported62. Human monocytes were isolated from the peripheral blood of normal human volunteers (blood donors at local blood bank) and were differentiated into mature macrophages as previously described63. Cells were cultured at specic densities as described in the text. The mouse macrophage cell lines IC21 and RAW 264.7 were purchased from the American Type Culture Collection (Rockville, MD) and were cultured in RPMI 1640 medium (Gibco BRL, Rockville, MD) supplemented with 10% fetal bovine serum, 100 U ml 1 of penicillin G and 100 mg ml 1 streptomycin and grown at 37 C in 5% CO2.
Experimental silicosis. Crystalline silica (a-quartz, average size, 1.7 mm) was obtained from US Silica Co. (Berkeley Springs, WV) and was selected by sedimentation according to Stokes law, acid hydrolysed and baked overnight (200 C, 16 h) to inactivate endotoxin contamination. Ten- to twelve-week-old Specic pathogen-free female C57BL/6 mice (Charles River Laboratories, Kingston, NY) weighing 2025 g were housed in pathogen-free cabinets. Animals were anaesthetized via intraperitoneal administration of sodium pentobarbital (200 mg kg 1;
Henry Schein, Indianapolis, IN), exposed to silica (0.2 g kg 1) or saline (control) and after 3 days received intravenous injections of human MSC or broblasts (500,000 cells per mouse), or human MSC-derived exosomes (B3 1011 exosomes
containing 40 mg protein). Animals were euthanized by exsanguinations at 3, 14 and 28 days post exposure. All lung samples were harvested at a terminal anaesthesia point, xed and embedded in parafn for histological analysis or snap-frozen in liquid nitrogen and stored at 80 C for RNA or collagen analysis. All pro
cedures involving animals were approval by the Institutional Animal Care and Use Committee of the University of Pittsburgh.
Collagen deposition was measured with hydroxyproline assay as previously described64. Briey, dried left lungs were acid-hydrolysed in 6 N HCl at 110 C under nitrogen gas. After evaporation of HCl, samples were suspended in PBS and incubated in a 60 C water bath. Following three consecutive high-speed centrifugations, a 40 dilution in PBS of the supernatant was oxidized with
chloramine-T and the reaction was stopped with perchloric acid. Finally, p-dimethylaminobenzaldehyde was added and samples were analysed spectrophotometrically at 557 nm. Hydroxyproline content per lung was calculated from a hydroxyproline standard curve.
Inammatory cells were measured in BALF of mice 28 days after the treatment with silica or intervention with MSCs, MSC-derived exosomes or broblasts. Mice were killed with an overdose of sodium pentobarbital and the lungs lavaged with a single instillation of 1 ml normal saline. Recovery of BALF was consistently above 80%. BALF cells were counted using a Z1 Coulter Particle Counter (Beckman Coulter Inc., Fullerton, CA), and 50,000 cells were transferred to glass slides using a Shandon Cytospin 4 (Thermo Electron Corporation, Pittsburgh, PA) at 750 r.p.m. for 5 min. After 3 days of drying, cells were stained using the Diff-Quick stain (Dade Behring, DE), and macrophages, neutrophils and lymphocytes were counted (400 cells).
Isolation of MVs. Purication of exosomes was performed as previously described17,18. Briey, MSCs were expanded in multilayer tissue culture plates (Millipore) in medium depleted of serum derived-MVs/exosomes by overnight ultracentrifugation at 100,000 g or in serum-reduced MSC medium (Invitrogen) supplemented with bovine serum albumin (Sigma-Aldrich). Conditioned medium from 10 106 MSCs was collected every 24 h and was subjected to successive
centrifugations at 300 and 2,000 g (10 min each) to remove cells. The cell-free supernatant was then centrifuged at 10,000 g for 30 min to remove cell debris and
100,000g (Beckman Coulter Optima L-90K ultracentrifuge) at 4 C for 90 min. The 10,000 and 100,000 g pellets were washed and suspended in 100 ml of PBS. Total protein was isolated from 25 106 MSCs and quantied using the Bradford
protein assay (Thermo Fisher Scientic). The protein content of exosomes (100,000g) or vesicles (10,000 g) recovered from conditioned medium was quantied (B35 mg per preparation) and pooled to perform electron microscopy, western blotting or in vivo administration.
Vesicles isolated from conditioned medium from 10 106 human MSCs were
pooled (ve to seven preparations) and overlaid on sucrose as previously described1618. Exosomes were suspended in 2 ml of 2.5 M sucrose and loaded in a SW41 tube, and 10 ml of a continuous sucrose gradient, from 2 to 0.25 M,was layered on top. Tubes were centrifuged for 18 h at 4 C at 100,000 g (ref. 18). Single 1-ml fractions were collected and sucrose density was determined on an aliquot of each gradient with the use of a refractometer (Reichert) and the fractions re-suspended in 3 ml PBS, centrifuged for 70 min at 100,000 g 4 C and the pellet suspended in sample buffer before being analysed with NanoSight tracker to determine particle number as previously described19, or SDSPAGE and western blot.
Measuring MSC-derived exosomes by nanoparticle tracking. Exosomes were diluted in particle-free PBS and measured using Nanoparticle Tracking Analysis as described19. Briey, videos were collected using a NanoSight LM10 system equipped with a 405-nm laser and a highly sensitive digital camera (OrcaFlas2.8, with camera shutter speed xed at 30.01 ms and gain set to 500), and analysed with the NTA software (NANOSight version 2.3). Ambient temperature was recorded manually and samples administered and recorded under control ow, using NanoSight syringe pump and script control system. For each sample, three videos of 60-s duration were obtained with 10-s delay between recordings, generating three replicate histograms. The typical number of tracks per sample was B1,500.
To obtain average particle counts, the area under the curve was calculated using the Prism-4 software. Black histograms indicate the average size concentration, and red error bars indicate the1 s.e. of the mean.
Western blotting and histochemistry. Western blot analysis was conducted as previously described44. The following primary (at a concentration of 1.5 mg ml 1)
and secondary (0.5 ng ml 1) antibodies were used for western blotting: polyclonal anti-ARRDC1, anti-LC3, anti-MDA5, anti-TLR9 (Abcam), polyclonal anti-Atg-12 (Santa Cruz Biotechnology, SC-68884), polyclonal anti-Pink1 (Santa Cruz Biotechnology, SC-33796), anti-Parkin mouse monoclonal (clone PRK8, Santa Cruz Biotechnology), polyclonal anti-Miro (Santa Cruz Biotechnology, SC-292547), anti-CD9 (MM2/57, Millipore), anti-CD63 (MEM-259, ThermoFisher), anti-TSG101 (51/TSG101, BD Biosciences), anti-Human MFGE8 (Abnova), anti-Dicer (D11, Santa Cruz Biotechnology, used at a concentration of 2 mg ml 1), anti-Tubulin, anti-LC3 (rabbit polyclonal), anti-TLR-7 (Cell Signaling
Technology), Beta actin (AC-15, Sigma-Aldrich) and anti-GAPDH (Santa Cruz Biotechnology, SC-25778). NF-kB nuclear translocation was characterized by staining cells with anti NF-kB-P50 Alexa Fluor 488 (E-10, Santa Cruz Biotechnology). Images were obtained using a Leica TCS NT upright confocal microscope.
Live cell imaging and electron microscopy. Human or mouse MSCs (1 106)
were infected with baculoviruses (BacMam2 delivery system, Life Technologies) encoding uorescent proteins (Organelle Lights, Life Technologies) to target mitochondria (GFP) or LC3-associated with phagosomes (RFP) for 48 h at 37 C at an multiplicity of infection of 30 in accordance with the manufacturers specications. Subsequently, 1 105 cells were plated into Mattek dishes and co-incubated with an
equal amount of bone marrow-derived macrophages (C57BL/6J, BALB/CJ and FVB/NJ) or macrophage cell lines (RAW 264.7 or IC-21). MSCs were maintained alive using a Tokai Hit temperature-controlled humidied chamber at 37 C for periods of up to 72 h. During this time, multimode imaging events in ve dimensions were obtained using high-speed confocal imaging on a Nikon Ti stand equipped with a Prairie Swepteld scanner and Elements software. Images were collected using shuttered illumination in two colours with cubes specically designed for GFP, ratiometric dyes or membrane/cytoplasmic labels, and differential interference contrast modes. Image series were viewed as movies for qualitative assessment, or were imported to Metamorph for quantitative assessment of cell motion, protein expression and organelle transfer between MSCs and macrophages. To inhibit the mitophagic ux, double GFP and RFP-labeled MSCs were treated with 3 mM chloroquine (Invitrogen) and images taken every 5 min as described. In some experiments, MSCs were stained with Cy5 dye (Amersham) following the manufacturers instructions; MSC-conditioned medium was collected and extracellular MVs isolated as described above. Cy5-labelled exosomes/MVs were co-cultured on Mattek dishes with macrophages from different mouse strains (C57BL/6J, BALB/CJ, TLR4 / , TLR9 / , MyD88 / , MARCO / and RAW 264.7) and
phagocytosis followed as described above. To inhibit phagocytosis, macrophages were treated for 2 h with 100 mg ml 1 dextran sulfate (Sigma-Aldrich) before their exposure to Cy5-labelled vesicles.
Electron microscopy analysis was performed on MSC extracellular vesicles loaded on carbon-coated grids and xed in 4% paraformaldehyde. Grids were
NATURE COMMUNICATIONS | 6:8472 | DOI: 10.1038/ncomms9472 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications 13
& 2015 Macmillan Publishers Limited. All rights reserved.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms9472
labelled with mouse or rabbit anti-human ATP synthase (ab54880). Grids were observed at 80 kV with a JEOL 1210 transmission electron microscope (TEM) with high-resolution AMT digital camera. Size of MVs was measured on ve to seven different pictures using the TEM software.
RNA analysis. RNA was extracted using the RNeasy micro kit (Qiagen), and rst-strand cDNA synthesized using SuperScript III (Invitrogen). Quantitative PCR was performed using the Taqman single-gene expression assay (Invitrogen) on an ABI 7900 Real Time PCR System (Applied Biosystems). The following oligonucleotide primers were used: hCOX-I (Hs03929097_g1), hGAPDH (Hs02596864_g1), mCOLLAGEN (Mm00472589_m1), mTNF (Mn 00443258_m1), mIL-6 (Mm00446190_m1), mIL-10 (Mm00439614_m1), mMyD88 (Mm00440338_m1), mTLR9 (Mm00446193), mTLR7 (Mm00446590_m1) and mTLR4 (Mm00445273_m1). Mouse Toll Like Receptor Signaling Pathway genes were measured using a mouse RT2 Proler PCR Array System (SABioscience Version 4) as previously described. Alternatively, total RNA was isolated from ve different human MSC donor populations or their exosomes using the Qiagen miRNeasy Mini Kit (PN 217004) according to the manufacturers instructions. Samples were then analysed using human microRNA microarrays from Agilent (Version 3, PN: G4470C) and data analysed using the Agilent GeneSpring GX 11 software. In some cases, array data were validated via quantitative RTPCR.mtDNA from ve human MSC donors was isolated, and human COXI, tRNA leucine and mitochondrial hypervariable regions I and II (HVRI) were sequenced to generate specic probes to allow for the documentation of fragment length polymorphism30. We identied polymorphisms in the sequences of HVR in each one of the ve hMSC donors used in the current study and partial homology in human tRNAleu probes between species that yielded a positive hybridization signal in mouse macrophages. Subsequently, we sequenced the COX gene from our ve human MSC donors and designed COX I-specic primers encompassing base pairs 64293 that were conserved among the different human MSC populations. In Supplementary Fig. 4 we illustrate sequences spanning nucleotides 108293 that exhibit little homology with the mouse gene and contain a BfaI restriction site (50-CTAG-30)
allowing the generation of a specic restriction map. PCR products were digested with BfaI and products resolved with agarose electrophoresis (Novex, Invitrogen).
Fluorescent activated cell sorting. Mouse lung tissue was digested with collagenase-dispase (Sigma-Aldrich) to generate a single-cell suspension as previously described50. Cells were then stained with the following antibodies: Anti-F4/80-FITC (BM8, Abcam), CCR2-PE (475301, R&D System), Ly-6C-APC (HK1.4, eBiosciences) and CD11b-V450 (M1/70, BD Biosciences). CD11b and Ly6Chi cells were gated within the F4/80 subpopulation, and from these CCR2 cells were sorted as previously described50. Characterization of exosomes markers was performed as described previously8,17. Aldehyde/sulfate latex beads (Life Technology) were coupled with 30 mg of exosomes, stained with uorescein isothiocyanate -conjugated anti-CD63 (H5C6, BD Pharmingen) and analysed using FACS. Macrophages co-incubated with Orange Fluorescent Protein (OFP)-mitochondria-labelled MSCs were incubated with anti-F4/80 and double-positive
F4/80 /RFP cells sorted using FACS. Analysis was performed using a FACS Canto II (BD Biosciences) and data analysed using the FlowJo v7.6.3 software.
Mitochondrial bioenergetics. Mitochondrial respiration in macrophages(35 108) was determined by measuring the OCR using an XF24 Extracellular
Flux Analyzer (Seahorse Bioscience). Macrophages were seeded at a density of 25,500 cells per well on the customized Seahorse 24-well plates. Cells were incubated in XF24 assay media for 1 h. OCR was calculated by plotting the O2 tension of the media in the chamber as a function of time (pmol min 1). Values were normalized to total protein content of each well. Data were collected from an average of six independent wells and experiments were conducted in triplicates. Where indicated, MSCs were stained with MitoSOX-Red (Invitrogen) to quantify mitochondrial superoxide production as previously described28. For microscopic analysis, 10 mM MitoSOX-Red was used, while 100 nM was used for uorescent quantication. To conrm mitochondrial localization of the dye, cells were counterstained with 5 mM Mito-Tracker Green (Invitrogen) for 10 min.
Normalization of uorescent data was performed using counterstaining with Hoechst 33342 (1 mM) for 5 min. Fluorescent wavelength pairs for the individual dyes were 510 nm/580 nm for MitoSOX-Red, and 490 nm/516 nm for Mito-Tracker Green. To determine mitochondrial membrane potential, cells were grownto B80% conuence in 96-well plates and stained with 2 mM JC-1 for 10 min following anisomycin treatment. Green uorescence (depolarization) was monitored at 488 nm and red uorescence (polarized) at 590 nm on a Spectromax M5e plate reader (Molecular Devices Inc., Sunnyvale, CA, http://www.moleculardevices.com
Web End =http://www.moleculardevices.com ). Actively growing cells were used as a negative control, and cells treated with 2 mM carbonyl cyanide p-triuorometho xyphenylhydrazone (FCCP) and 1 mM valinomycin were used as the positive control. Normalization to cell number was achieved as described above. Data are presented as per cent viable cells based on presumed 95100% depolarization observed in FCCP/valinomycin-treated cells37.
DICER knockdown in human MSCs. Human MSCs (1 106) were infected with a
lentivirus encoding a DICER-specic shRNA l (Santa Cruz Biotechnology) in complete aMEM containing 5 mg ml 1 Polybrene overnight at 37 C 5% CO2.
Clones expressing the virus were selected by their resistance to Puromycin (Sigma-Aldrich) and reduced DICER expression in selected cells was conrmed by western blotting using an anti-hDICER antibody (H-212, Santa Cruz Biotechnology).
Statistics. Results are presented as means.e.m. from at least three experiments. Statistical differences between groups were analysed using one-way ANOVA followed by SNK test for post hoc pairwise comparisons (statview 4, Abacus Concenpt Inc, Berkely, CA). For microarray data, the signicant differences were determined by one-way ANOVA with HolmSidak all pairwise multiple comparison procedure. The statistical signicance of differences was set at Po0.05.
References
1. Caplan, A. I. & Correa, D. The MSC: an injury drugstore. Cell Stem Cell 9, 1115 (2011).
2. Pittenger, M. Sleuthing the source of regeneration by MSCs. Cell Stem Cell 5, 810 (2009).
3. Ortiz, L. A. et al. Interleukin 1 receptor antagonist mediates the antiinammatory and antibrotic effect of mesenchymal stem cells during lung injury. Proc. Natl Acad. Sci. USA 104, 1100211007 (2007).
4. Lee, J. W., Fang, X. H., Gupta, N., Serikov, V. & Matthay, M. A. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc. Natl Acad. Sci. USA 106, 1635716362 (2009).
5. Timmers, L. et al. Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium. Stem Cell Res. 1, 129137 (2007).
6. van Niel, G., Porto-Carreiro, I., Simoes, S. & Raposo, G. Exosomes: a common pathway for a specialized function. J. Biochem. 140, 1321 (2006).
7. Lotvall, J. & Valadi, H. Cell to cell signalling via exosomes through esRNA. Cell Adh. Migr. 1, 156158 (2007).
8. Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654659 (2007).
9. Cocucci, E., Racchetti, G. & Meldolesi, J. Shedding microvesicles: artefacts no more. Trends Cell Biol. 19, 4351 (2009).
10. Cocucci, E. & Meldolesi, J. Ectosomes. Curr. Biol. 21, R940R941 (2011).11. Nabhan, J. F., Hu, R. X., Oh, R. S., Cohen, S. N. & Lu, Q. Formation and release of arrestin domain-containing protein 1-mediated microvesicles (ARMMs) at plasma membrane by recruitment of TSG101 protein. Proc. Natl Acad. Sci. USA 109, 41464151 (2012).
12. Lai, R. C. et al. Exosome secreted by MSC reduces myocardial ischemia/ reperfusion injury. Stem Cell Res. 4, 214222 (2010).
13. Bruno, S. et al. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J. Am. Soc. Nephrol. 20, 10531067 (2009).
14. Lee, C. et al. Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension. Circulation 126, 26012611 (2012).
15. Cantaluppi, V. et al. Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microRNA-dependent reprogramming of resident renal cells. Kidney Int. 82, 412427 (2012).
16. Heijnen, H. F. G., Schiel, A. E., Fijnheer, R., Geuze, H. J. & Sixma, J. J. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 94, 37913799 (1999).
17. Thery, C., Amigorena, S., Raposo, G. & Clayton, A. Isolation and characterization of exosomes from cell culture supernatants and biological uids. Curr. Protoc. Cell Biol. Chapter 3, Unit 3 22 (2006).
18. Bobrie, A., Colombo, M., Krumeich, S., Raposo, G. & Thry, C. Diverse subpopulations of vesicles secreted by different intracellular mechanisms are present in exosome preparations obtained by differential ultracentrifugation.J. Extracell. Vesicles 1, 18397 (2012).19. Webber, J. & Clayton, A. How pure are your vesicles? J. Extracell. Vesicles 2, 19861 (2013).
20. Ehninger, A. & Trumpp, A. The bone marrow stem cell niche grows up: mesenchymal stem cells and macrophages move in. J. Exp. Med. 208, 421428 (2011).
21. Morrison, S. J. & Scadden, D. T. The bone marrow niche for haematopoietic stem cells. Nature 505, 327334 (2014).
22. Kiel, M. J. et al. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121, 1109 1121 (2005).
23. Mendez-Ferrer, S. et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466, 829834 (2010).
24. Chow, A. et al. Bone marrow CD169 macrophages promote the retention
of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche.J. Exp. Med. 208, 261271 (2011).
14 NATURE COMMUNICATIONS | 6:8472 | DOI: 10.1038/ncomms9472 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms9472 ARTICLE
25. Chow, A. et al. CD169( ) macrophages provide a niche promoting
erythropoiesis under homeostasis and stress. Nat. Med. 19, 429436 (2013).26. Spencer, J. A. et al. Direct measurement of local oxygen concentration in the bone marrow of live animals. Nature 508, 269273 (2014).
27. Nombela-Arrieta, C. et al. Quantitative imaging of haematopoietic stem and progenitor cell localization and hypoxic status in the bone marrow microenvironment. Nat. Cell Biol. 15, 533543 (2013).
28. Boregowda, S. V. et al. Atmospheric oxygen inhibits growth and differentiation of marrow-derived mouse mesenchymal stem cells via a p53-dependent mechanism: implications for long-term culture expansion. Stem Cells (Dayton, Ohio) 30, 975987 (2012).
29. Al Rawi, S. et al. Postfertilization autophagy of sperm organelles prevents paternal mitochondrial DNA transmission. Science 334, 11441147 (2011).
30. Spees, J. L., Olson, S. D., Whitney, M. J. & Prockop, D. J. Mitochondrial transfer between cells can rescue aerobic respiration. Proc. Natl Acad. Sci. USA 103, 12831288 (2006).
31. Plotnikov, E. Y. et al. Cell-to-cell cross-talk between mesenchymal stem cells and cardiomyocytes in co-culture. J. Cell Mol. Med. 12, 16221631 (2008).32. Plotnikov, E. Y., Khryapenkova, T. G., Galkina, S. I., Sukhikh, G. T. & Zorov, D. B. Cytoplasm and organelle transfer between mesenchymal multipotent stromal cells and renal tubular cells in co-culture. Exp. Cell Res. 316, 24472455 (2010).
33. Islam, M. N. et al. Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat. Med. 18, 759765 (2012).
34. Zhang, Q., Itagaki, K. & Hauser, C. J. Mitochondrial DNA is released by shock and activates neutrophils via P38 MAP kinase. Shock 34, 5559 (2010).
35. Oka, T. et al. Mitochondrial DNA that escapes from autophagy causes inammation and heart failure. Nature 485, 251U142 (2012).
36. Ishikawa, K. et al. The innate immune system in host mice targets cells with allogenic mitochondrial DNA. J. Exp. Med. 207, 22972305 (2010).
37. Troiano, L. et al. Multiparametric analysis of cells with different mitochondrial membrane potential during apoptosis by polychromatic ow cytometry. Nat. Protoc. 2, 27192727 (2007).
38. Kane, L. A. & Youle, R. J. PINK1 and Parkin ag Miro to direct mitochondrial trafc. Cell 147, 721723 (2011).
39. Klionsky, D. J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 8, 445544 (2012).
40. Hansen, T. E. & Johansen, T. Following autophagy step by step. BMC Biol. 9, 39 (2011).
41. Kuo, L. & Freed, E. O. ARRDC1 as a mediator of microvesicle budding. Proc. Natl Acad. Sci. USA 109, 40254026 (2012).
42. Lee, R. H. et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inammatory protein TSG-6. Cell Stem Cell 5, 5463 (2009).
43. Zhang, C. L., Rodenkirch, L., Schultz, J. R. & Chiu, S. Y. A novel method to study the local mitochondrial fusion in myelinated axons in vivo. J. Neurosci. Methods 207, 5158 (2012).
44. Di Giuseppe, M. et al. Systemic inhibition of NF-R B activation protects from silicosis. PLoS ONE 4, e5689 (2009).
45. Nemeth, K. et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat. Med. 15, 4249 (2009).
46. Sanjuan, M. A. et al. Toll-like receptor signalling in macrophageslinks the autophagy pathway to phagocytosis. Nature 450, 12531257 (2007).
47. Cifuentes, D. et al. A novel miRNA processing pathway independent of dicer requires argonaute2 catalytic activity. Science 328, 16941698 (2010).
48. Rosenberger, C. M. et al. miR-451 regulates dendritic cell cytokine responses to inuenza infection. J. Immunol. 189, 59655975 (2012).
49. Aliotta, J. M. et al. Microvesicle entry into marrow cells mediates tissue-specic changes in mRNA by direct delivery of mRNA and induction of transcription. Exp. Hematol. 38, 233245 (2010).
50. Gibbons, M. A. et al. Ly6C(hi) monocytes direct alternatively activated probrotic macrophage regulation of lung brosis. Am. J. Resp. Crit. Care 184, 569581 (2011).
51. Misharin, A. V., Morales-Nebreda, L., Mutlu, G. M., Budinger, G. R. & Perlman, H. Flow cytometric analysis of macrophages and dendritic cell subsets in the mouse lung. Am. J. Respir. Cell Mol. Biol. 49, 503510 (2013).
52. Ahmad, T. et al. Miro1 regulates intercellular mitochondrial transport & enhances mesenchymal stem cell rescue efcacy. EMBO J. 33, 9941010 (2014).
53. Cho, Y. M. et al. Mesenchymal stem cells transfer mitochondria to the cells with virtually no mitochondrial function but not with pathogenic mtDNA mutations. PLoS ONE 7, e32778 (2012).
54. King, M. P. & Attardi, G. Injection of mitochondria into human-cells leads to a rapid replacement of the endogenous mitochondrial-DNA. Cell 52, 811819 (1988).
55. King, M. P., Attardi, G. & Human-Cells Lacking Mtdna - repopulation with exogenous mitochondria by complementation. Science 246, 500503 (1989).
56. Huang, X. et al. Characterization of human plasma-derived exosomal RNAs by deep sequencing. BMC Genomics 14, 319 (2013).
57. Kukat, C. et al. Super-resolution microscopy reveals that mammalian mitochondrial nucleoids have a uniform size and frequently contain a single copy of mtDNA. Proc. Natl Acad. Sci. USA 108, 1353413539 (2011).
58. Zhang, Z. et al. MicroRNA-451 regulates p38 MAPK signaling by targeting of Ywhaz and suppresses the mesangial hypertrophy in early diabetic nephropathy. FEBS Lett. 586, 2026 (2012).
59. Masaki, S., Ohtsuka, R., Abe, Y., Muta, K. & Umemura, T. Expression patterns of microRNAs 155 and 451 during normal human erythropoiesis. Biochem. Biophys. Res. Commun. 364, 509514 (2007).
60. Bandres, E. et al. microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. Clin. Cancer Res. 15, 22812290 (2009).
61. Sekiya, I. et al. Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells (Dayton, Ohio) 20, 530541 (2002).
62. Davies, J. Q. & Gordon, S. Isolation and culture of murine macrophages. Methods Mol. Biol. 290, 91103 (2005).
63. Vogt, G. & Nathan, C. In vitro differentiation of human macrophages with enhanced antimycobacterial activity. J. Clin. Invest. 121, 38893901 (2011).
64. Redente, E. F. et al. Tumor necrosis factor-alpha accelerates the resolution of established pulmonary brosis in mice by targeting probrotic lung macrophages. Am. J. Respir. Cell Mol. Biol. 50, 825837 (2014).
Acknowledgements
We thank Mr Brian Brockway for technical assistance with histological analysis and Dr Clotilde Thry from the Pasteur Institute for her advice regarding exosome isolation. This work was funded by National Institutes of Health grants to L.A.O. (R01HL114795, R01HL110334) and D.G.P. (R24 OD018254). Clinical grade human MSCs were provided by the NHLBI-sponsored Production Assistance for Cellular Therapies Program at the University of Minnesota (Contract HHSN268201000008C).
Author contributions
L.A.O. and D.G.P. conceived the project, supervised the studies and wrote the manuscript. M.D.G., J.N., E.S. and S.V.B. designed and conducted experiments. J.K. contributed to mouse and monocyte studies. N.K., Y.P.D., G.D.L and G.D. contributed to RNA and microRNA studies. C.M.S.C., D.B.S. and S.C.W. conducted live image and electron microscopy studies. D.W.H.R. contributed to pathological assessment of mouse tissue. S.S. contributed to macrophage biogenesis studies. D.H.M. provided clinical-grade human MSCs.
Additional information
Accession codes: Microarray data have been deposited in the GEO NCBI database with accession code GSE71241.
Supplementary Information accompanies this paper at http://www.nature.com/naturecommunications
Web End =http://www.nature.com/ http://www.nature.com/naturecommunications
Web End =naturecommunications
Competing nancial interests: The authors declare no competing nancial interests.
Reprints and permission information is available online at http://npg.nature.com/reprintsandpermissions/
Web End =http://npg.nature.com/ http://npg.nature.com/reprintsandpermissions/
Web End =reprintsandpermissions/
How to cite this article: Phinney, D. G. et al. Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs. Nat. Commun. 6:8472doi: 10.1038/ncomms9472 (2015).
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the articles Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
Web End =http://creativecommons.org/licenses/by/4.0/
NATURE COMMUNICATIONS | 6:8472 | DOI: 10.1038/ncomms9472 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications 15
& 2015 Macmillan Publishers Limited. All rights reserved.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Copyright Nature Publishing Group Oct 2015
Abstract
Mesenchymal stem cells (MSCs) and macrophages are fundamental components of the stem cell niche and function coordinately to regulate haematopoietic stem cell self-renewal and mobilization. Recent studies indicate that mitophagy and healthy mitochondrial function are critical to the survival of stem cells, but how these processes are regulated in MSCs is unknown. Here we show that MSCs manage intracellular oxidative stress by targeting depolarized mitochondria to the plasma membrane via arrestin domain-containing protein 1-mediated microvesicles. The vesicles are then engulfed and re-utilized via a process involving fusion by macrophages, resulting in enhanced bioenergetics. Furthermore, we show that MSCs simultaneously shed micro RNA-containing exosomes that inhibit macrophage activation by suppressing Toll-like receptor signalling, thereby de-sensitizing macrophages to the ingested mitochondria. Collectively, these studies mechanistically link mitophagy and MSC survival with macrophage function, thereby providing a physiologically relevant context for the innate immunomodulatory activity of MSCs.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer